Contraindications for 10 mg Intramuscular Biotin Injection
There are no absolute contraindications to 10 mg intramuscular biotin injection based on current evidence. Biotin has an exceptionally safe profile with no established upper limit (UL) for toxicity, and no adverse effects have been documented even with prolonged use of pharmacological doses 1.
Safety Profile
The 2022 ESPEN Micronutrient Guideline explicitly states that biotin toxicity is unlikely and no adverse effects have been shown for both oral and IV administration of pharmacological doses up to 5 mg/day for prolonged periods 1. More importantly, the guideline notes that in deficient parenteral nutrition-dependent patients, IV doses up to 200 mg/day for 2-3 weeks may be required 1—far exceeding the 10 mg IM dose in question.
Research confirms this safety profile. A comprehensive safety assessment found little acute oral toxicity in animal tests, and short-term and subchronic toxicity studies found no evidence of toxicity 2. The only documented adverse reaction in humans is a single case report of an urticarial reaction, which is extraordinarily rare given the massive number of individuals exposed to biotin daily 2.
Important Clinical Caveat: Laboratory Test Interference
While biotin itself has no contraindications, you must be aware of a critical laboratory interference issue:
- High-dose biotin (≥5-10 mg) can cause falsely abnormal results in immunoassays that use streptavidin-biotin technology 3, 4, 5
- This can create a false clinical picture of hyperthyroidism (elevated T4L and T3L, suppressed TSH, positive TSH receptor antibodies) when the patient is actually euthyroid 3
- Biotin interference can also affect parathyroid hormone and 25-hydroxyvitamin D measurements 5
- Instruct patients to discontinue biotin 48-72 hours before any laboratory testing to avoid erroneous results 4
Special Populations
Pregnancy and lactation: Not only is biotin safe, but requirements may actually be higher during pregnancy. Studies suggest pregnant women may need 300 mcg or more daily 1. Breastfeeding mothers should receive at least 35 mcg daily 1.
Renal replacement therapy: Additional biotin amounts may be needed in patients on dialysis 1.
Route of Administration
The 10 mg IM dose is well within established safe ranges. The ESPEN guideline confirms that additional amounts of biotin can be administered orally, enterally, or IV depending on intestinal function 1—IM administration falls within this spectrum of safe delivery methods.
Bottom Line
Proceed with the 10 mg IM biotin injection without hesitation from a safety standpoint. Your only action item is to document that the patient should avoid laboratory testing for 48-72 hours after injection or inform the laboratory of biotin supplementation if urgent testing is required.